Aphakia clinical trials
The registry lists 69 studies for Aphakia across more than 10 countries. 6 are recruiting or about to start. 55 of them are mainly about Aphakia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.
Get an email when these change. Save the Aphakia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Alcon Research (23) · RxSight, Inc. (8) · Hoya Surgical Optics, Inc. (4) · Bausch & Lomb Incorporated (3) · ClarVista Medical (3) · Ophtec USA (2) · PowerVision (2) · Tomey Corporation (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Jul 2027Clinical Evaluation of a Novel Trifocal IOL · Alcon Research
Who these studies take
Of the 6 Aphakia studies recruiting now, 4 (67%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (17%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (17%) | 1 (17%) |
| 30 | 5 (83%) | 5 (83%) |
| 40 | 5 (83%) | 5 (83%) |
| 50 | 6 (100%) | 6 (100%) |
| 65 | 6 (100%) | 6 (100%) |
| 75 | 6 (100%) | 6 (100%) |
| 85 | 5 (83%) | 5 (83%) |
Across all 69 studies, recruiting or not: 6% stop at 75 or younger and 6% at 65; 14% take children; 0% are for women only and 0% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Aphakia studies take
Of 37 interventional studies with no phase under Aphakia, half reached primary completion within 17 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 17 mo9–26 · 37 studies | 17 mo9–23 · 32 studies | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting1
- Clinical Evaluation of a Novel Trifocal IOLOct 21, 2026NCT07587138
Stopped1
- Feasibility Study of an Accommodating IOL DesignTerminatedOct 29, 2026NCT07147192
Studies
Recruiting first, then most recently updated. Showing 50 of 69. Browse all 69 → or search them.
- Clareon TruPlus StudyRecruitingNCT07502456Not applicable1 country
- Clinical Evaluation of a Novel Trifocal IOLRecruitingNCT07587138Not applicable3 countries
- Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOLRecruitingNCT06258707Not applicable1 country
- Comparison of Two Different Intraocular Lenses Implanted With Yamane TechniqueRecruitingNCT059128291 country
- Comparative Study of the Tomey OA-2000, Tomey CASIA2, and the LenStar LS900RecruitingNCT060650721 country
- Sutureless Intrascleral Intraocular Lens Fixation and Modified Iris Cerclage PupilloplastyRecruitingNCT05829122Not applicable1 country
- Contralateral Claims Study of Clareon Vivity ProActive, not recruitingNCT07484191Not applicable1 country
- Feasibility Study of an Accommodating IOL DesignTerminatedNCT07147192Not applicable4 countries
- Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLsCompletedNCT07161635Not applicable1 country
- Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment StudyCompletedNCT073473791 country
- Comparison of Aspheric Toric & Non-toric Aphakic Intraocular LensesTerminatedNCT01268540Not applicable1 country
- Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular LensCompletedNCT00625313Not applicable1 country
- Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.CompletedNCT01292629Not applicable1 country
- Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptixCompletedNCT05796453Not applicable2 countries
- Clareon Toric Study (T2-T9)CompletedNCT06285695Not applicable1 country
- Horizontal vs Vertical Scleral Tunnels in Flanged IOL FixationCompletedNCT077019801 country
- Clareon PanOptix Pro vs. Clareon PanOptix - Study BCompletedNCT06401551Not applicable1 country
- Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)CompletedNCT06166901Not applicable1 country
- Evaluation of Clareon Vivity/Vivity ToricCompletedNCT05852470Not applicable1 country
- Clareon PanOptix Pro vs. Clareon PanOptix - Study ACompletedNCT06400745Not applicable1 country
- Evaluation of AcrySof IQ Vivity Extended Vision Intraocular LensesWithdrawnNCT06541795Not applicable1 country
- A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular LensesCompletedNCT057999502 countries
- RxSight Light Adjustable Lens and Light Delivery Device New Enrollment StudyCompletedNCT05202808Not applicable1 country
- Iris Suture Fixation vs Iris Claw for Correction of AphakiaCompletedNCT06933654Not applicable1 country
- Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual OutcomesCompletedNCT045296161 country
- Intravitreal Injection Site and Perceived PainCompletedNCT056408951 country
- A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of FocusTerminatedNCT041777711 country
- Clareon Toric vs Eyhance ToricCompletedNCT05481125Not applicable1 country
- Artisan Aphakia Lens for the Correction of Aphakia in ChildrenSuspendedNCT01547442Not applicable2 countries
- Artisan Aphakia Lens for the Correction of Aphakia (Secondary) in AdultsSuspendedNCT01547429Not applicable2 countries
- Infant Aphakia Treatment Study (IATS)CompletedNCT00212134Not applicable1 country
- Registry Study on Intraocular Lenses Manufactured by Teleon Surgical B.V.CompletedNCT052908701 country
- Anterior Versus Posterior Artisan Intraocular Lens Fixation in Aphakic Children With Insufficient Capsular Support.CompletedNCT06396156Not applicable1 country
- Comparison of Safety and Efficacy of Four-Point Scleral Intraocular Lens Fixation and Yamane TechniquesCompletedNCT06389643Not applicable1 country
- Clinical Evaluation of the Lenstec Softec HP1 Intraocular LensCompletedNCT03900260Not applicable1 country
- Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLsCompletedNCT03733730Not applicable2 countries
- Clareon IOL Retrospective Data CollectionCompletedNCT057966741 country
- Post-Market Clinical Study of the PanOptix Intraocular Lens (IOL) in a Chinese PopulationCompletedNCT04755231Not applicable1 country
- Real-World Study of Vivity Intraocular Lenses (IOLs)WithdrawnNCT04800016Not applicable1 country
- Post-Market Clinical Investigation of the Clareon® IOLCompletedNCT03316885Not applicable7 countries
- Exploratory Clinical Study for Techniques Associated With the Fluid Accommodating IOLCompletedNCT04330001Not applicable2 countries
- Prospective Clinical Trial to Evaluate the Safety and Effectiveness of the IOLCompletedNCT03451786Not applicable1 country
- Clinical Investigation of the Visual Outcomes and Safety of a Trifocal Toric IOL in an Asian PopulationCompletedNCT04528069Not applicable1 country
- Clinical Investigation of an AcrySof IQ PanOptix Toric Intraocular LensCompletedNCT04542525Not applicable1 country
- Exploratory Study to Evaluate the Use of the RxSight Light Adjustable Lens (LAL) and the Light Delivery Device (LDD) to Improve Visual OutcomesCompletedNCT038950341 country
- Clinical Investigation of the AcrySof IQ Vivity Extended Vision Intraocular Lens (IOL)CompletedNCT04098367Not applicable2 countries
- Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive SurgeryCompletedNCT03660865Not applicable1 country
- Exploratory Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RXLAL) With The Light Delivery Device (LDD) in Subjects With Preoperative Corneal AstigmatismCompletedNCT03729024Not applicable1 country
- A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)CompletedNCT04005586Not applicable1 country
- Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) With an Improved Injector SystemCompletedNCT02418871Not applicable2 countries